The Somatostatin Analog 188Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts

Carol A. Nelson; Michael T. Azure; Christopher T. Adams; Kurt R. Zinn

doi:10.2967/jnumed.114.140780

Research ArticleBasic Science Investigations

The Somatostatin Analog ¹⁸⁸Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts

Carol A. Nelson, Michael T. Azure, Christopher T. Adams and Kurt R. Zinn

Journal of Nuclear Medicine December 2014, 55 (12) 2020-2025; DOI: https://doi.org/10.2967/jnumed.114.140780

Carol A. Nelson

1Translational Medicine Consulting, Westford, Massachusetts

2Department of Research and Development, Andarix Pharmaceuticals, Watertown, Massachusetts; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael T. Azure

3Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christopher T. Adams

2Department of Research and Development, Andarix Pharmaceuticals, Watertown, Massachusetts; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kurt R. Zinn

3Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 55, Issue 12

December 1, 2014

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following The Somatostatin Analog 188Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

The Somatostatin Analog ¹⁸⁸Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts

Carol A. Nelson, Michael T. Azure, Christopher T. Adams, Kurt R. Zinn

Journal of Nuclear Medicine Dec 2014, 55 (12) 2020-2025; DOI: 10.2967/jnumed.114.140780

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

The Somatostatin Analog ¹⁸⁸Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts

Carol A. Nelson, Michael T. Azure, Christopher T. Adams, Kurt R. Zinn

Journal of Nuclear Medicine Dec 2014, 55 (12) 2020-2025; DOI: 10.2967/jnumed.114.140780

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

somatostatin
AR42J pancreatic tumor
radiotherapeutic
neuroendocrine
pancreas

Main menu

User menu

Search

The Somatostatin Analog ¹⁸⁸Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords